Remove 2025 Remove Licensing Remove Marketing Remove Registration
article thumbnail

Recent Biosimilar Commercialization Developments

LexBlog IP

has announced an exclusive licensing agreement with Tonghua Dongbao Pharmaceuticals Co., to commercialize several of Abbott’s oncology, women’s health, and respiratory disease biosimilars for emerging markets in Latin America, Southeast Asia, the Middle East, and Africa. Insulin Biosimilars: Meitheal Pharmaceuticals, Inc.

article thumbnail

SpicyIP Weekly Review (July 1-July 7)

SpicyIP

CGPDTM Announces Dates for 2025 Trademark and Patent Agent Exams Dates for Trademark and Patent Agent Exams 2025 have been announced by the CGPDTM. The Trademark Agent Exam is likely to be held on January 04, 2025 and the Patent Agent Exam is likely to be held on January 5, 2025. Microsoft Technology Licensing LLC v.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Corporate Transparency Act (Part 1): An Overview

LexBlog IP

Any reporting company that is created or registered before January 1, 2024, must file a BOI report no later than January 1, 2025.

article thumbnail

The Corporate Transparency Act (Part 1): An Overview

LexBlog IP

Any reporting company that is created or registered before January 1, 2024, must file a report no later than January 1, 2025. Reports will not be accepted prior to January 1, 2024.

article thumbnail

What Business Owners Need to Know About the Corporate Transparency Act

LexBlog IP

Each Reporting Company is required to report: Entity name (and any alternative trade or d/b/a name); Business street address; Jurisdiction of formation and, for foreign entities, the State or Tribal jurisdiction of registration; and A unique identification number (such as TIN, EIN, LEI, etc.). When do I Need to Report By?

article thumbnail

The Jakarta Effect: Could Southeast Asia’s Consensus-Based Remuneration Approach Be the Blueprint for Human-Centric AI?

Kluwer Copyright Blog

In this post, the focus is on the unlicensed use of copyright-protected works in the context of training GenAI models, where such use could jeopardise the market for those particular expressions (see Sobel ). It appears that a one-size-fits-all approach to training data licensing may not be optimal for the ASEAN.

article thumbnail

IP and Cannabis: The Current Landscape

Fish & Richardson Trademark & Copyright Thoughts

billion by 2025. [ii] The 2018 Farm Bill led to widespread availability of products containing CBD, which are commonly marketed as dietary supplements, drugs, food, and cosmetics. State-level trademark registrations confer many of the same advantages as federal registration, but are limited to the state in which the mark is registered.

IP 52